Orthopedic Surgery: Clinical Trials

4 completed. 4 Phase 2, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	4	Completed 4
Phase 3	2	Completed 2

Follow Orthopedic Surgery: new trials by email Literature Review of Orthopedic Surgery trials Research Report on Orthopedic Surgery

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Evaluating the Influence of the Strategy Intraoperative Anesthetic (Desflurane Versus Propofol) on Cognitive and Psychomotor Functions in Output Post Interventional Room Monitoring - COGNIDES Intraoperative anesthetic strategy by Propofol, Intraoperative anesthetic strategy by Desflurane - Orthopedic Surgery, Total Hip Prosthesis	Phase 2	Completed	Assistance Publique - Hôpitaux de Paris	60	2013-04-01	2014-12-23
Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy Lornoxicam 8 mg, Lornoxicam 16 mg, Ketorolac 30 mg - Bunionectomy, Orthopedic Surgery	Phase 2	Completed	POZEN	100	2005-11-01	2012-12-03
A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery epoetin alfa - Blood Transfusion, Blood Transfusion, Autologous	Phase 2 / Phase 3	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	80	1990-01-01	2011-05-18
A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery. epoetin alfa - Blood Transfusion, Blood Transfusion, Autologous	Phase 2 / Phase 3	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	112		2011-05-18

Interventions

Epoetin Alfa (2)  ·  Ketorolac (1)  ·  lornoxicam (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  POZEN (1)

Countries

France (1)  ·  United States (1)

Top investigators

Cyrille Robert, PH (1)  ·  Michael P. DeMicco, MD (1)